Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KB-1473

Zalutumumab

Home » Antibodies » Zalutumumab

Background of Zalutumumab

Zalutumumab (proposed trade name HuMax-EGFR) is a high-affinity, fully human IgG1 monoclonal antibody (mAb) targeting the epidermal growth factor receptor (EGFR), also known as ErbB1/HER1. Developed by Genmab, this antibody is designed for the treatment of squamous cell carcinoma of the head and neck (SCCHN), a specific type of cancer.Zalutumumab originates from transgenic mice immunized with A431-derived EGFR. In 2009, the U.S. Food and Drug Administration (FDA) granted Fast Track status to zalutumumab for patients with SCCHN who have failed standard therapies and have no other treatment options available.

Specifications

Catalog Number:
KB-1473
Antibody Name:
Zalutumumab
Isotype:
Human IgG1,kappa
FC Muations:
Target:
EGFR
Species Reactivity:
Human
Host Cell Line:
EXPI CHO
Purification Method:
Affinity purified
Concentration:
>2 mg/mL
Formulation:
50 mM sodium citrate,150mM NaCl,pH5.5
Purity:
>95% by SDS-PAGE and SEC-HPLC
Validation:
ELISA
Endotoxin Level:
<0.2 EU/mg as determined by the LAL method
Sterility:
0.2μm filtered
Storage:
It is recommended that the protein should be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Stability:
Stable for twelve months from date of receipt when stored at -20°C to -80°C; Stored at 2-8°C for one month without detectable loss of activity.

Characterization

Application

References

  1. Lammerts van Bueren JJ, Bleeker WK, Brännström A, von Euler A, Jansson M, Peipp M, Schneider-Merck T, Valerius T, van de Winkel JG, Parren PW (April 2008). "The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility". Proceedings of the National Academy of Sciences of the United States of America. 105 (16): 6109–14.